Estimated Costs of Clinical and Surgical Treatment of Severe Obesity in the Brazilian Public Health System

Obes Surg. 2017 Dec;27(12):3273-3280. doi: 10.1007/s11695-017-2776-5.

Abstract

Background: Obesity is a major global epidemic and a burden to society and health systems. This study aimed to estimate and compare the anual costs of clinical and surgical treatment of severe obesity from the perspective of the Brazilian Public Health System.

Methods: An observational and cross-sectional study was performed in three reference centers. Data collection on health resources utilization and productivity loss was carried out through an online questionnaire. Participants were divided in clinical (waiting list for a bariatric surgery) and surgical groups (open Roux-en-Y gastric bypass), and then allocated by the time of surgery (up to 1 year; 1-2 years; 2-3 years; and >3 years). Costs of visits, medications, exams, and surgeries were obtained from government sources. Data on non-medical costs, such as transportation, special diets, and caregivers, were also colleted. Productivity loss was estimated using self-reported income. Costs in local currency (Real) were converted to international dollars (Int$ 2015).

Results: Two hundred and seventy-four patients, 140 in surgical group and 134 in clinical group were included. In first postoperative year, the surgical group had higher costs than clinical group (Int$6005.47 [5000.18-8262.36] versus 2148.14 [1412.2-3506.8]; p = 0.0002); however, from the second year, the costs decreased progressively. In the same way, indirect costs decreased significantly after surgery (259.08 [163.63-662.72] versus 368.17 [163.62-687.27]; p = 0.06).

Conclusion: Total costs were higher in the surgical group in the first 2 years after surgery. However, from the third year on, the costs were lower than in the clinical group.

Keywords: Bariatric surgery; Costs and cost analysis; Healthcare costs; Obesity.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Anti-Obesity Agents / economics*
  • Anti-Obesity Agents / therapeutic use*
  • Bariatric Surgery / economics*
  • Bariatric Surgery / statistics & numerical data
  • Brazil / epidemiology
  • Costs and Cost Analysis
  • Cross-Sectional Studies
  • Diet Therapy / economics
  • Diet Therapy / statistics & numerical data
  • Female
  • Health Care Costs
  • Humans
  • Male
  • Middle Aged
  • Obesity, Morbid / economics*
  • Obesity, Morbid / epidemiology
  • Obesity, Morbid / therapy*
  • Public Health / economics
  • Weight Reduction Programs / economics
  • Weight Reduction Programs / statistics & numerical data

Substances

  • Anti-Obesity Agents